NEW YORK ( TheStreet) -- CHANGE IN RATINGS Activision Blizzard ( ATVI) rated new Outperform at Credit Suisse. $16 price target. Company can continue to expand around the globe. Celgene ( CELG) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $86 price target. Company lacks near-term catalysts. Check Point ( CHKP) downgraded at Needham from Buy to Hold, Needham said. Recent field checks suggest that sales could slow down in the coming quarters. Cott Corp ( COT) rated new Buy at Citigroup. $10 price target. Strong EPS growth driven by a balance of factors. Chevron ( CVX) rated new Hold at Dahlman. Two major LNG projects add risk to the thesis. DR Horton ( DHI) downgraded at MKM from Buy to Neutral, MKM Partners said. Valuation call, as the sector has already made a big run. Electronic Arts ( ERTS) rated new Neutral at Credit Suisse. $16 price target. Company has struggled with its digital transition. FedEx ( FDX) upgraded at Standpoint from Hold to Buy, Standpoint said. $130 price target. Company is cutting costs and annual earnings can approach $10 a share. Genomic Health ( GHDX) rated new Neutral at Goldman. $36 price target. Company has limited earnings upside potential. Host Hotels ( HST) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Expect slower industry RevPAR growth. Johnson Controls ( JCI) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Management will struggle to turn the company around by 2013. Lennar ( LEN) downgraded at MKM from Buy to Neutral, MKM Partners said. See limited upside to near-term earnings expectations. Marriott ( MAR) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock has outperformed the market year-to-date. MetroPCS Communications ( PCS) downgraded at Oppenheimer to Underperform from Perform, Oppenheimer said. Wireless to eventually consolidate into three players. Rite Aid ( RAD) rated new Buy at BTIG. $2.25 price target. Company is improving customer retention and margins. Texas Instruments ( TXN) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $26 price target. Company is leveraged to slower macro growth. Exxon Mobil ( XOM) rated new Buy at Dahlman. $100 price target. Company will continue to buy back stock in the coming quarters.
Zynga ( ZNGA) rated new Underperform at Credit Suisse. $3 price target. Company is losing customers, even for new games.
Twitter and become a fan on Facebook.
STOCK COMMENTS / EPS CHANGESAdtran ( ADTN) numbers lowered at Jefferies. Shares of ADTN now seen reaching $13.25, Jefferies said. Estimates also lowered on ugly Q3. Underperform rating. Dean Foods ( DF) numbers cut at UBS. Shares of DF now seen reaching $15.50, UBS said. Estimates also lowered on heightened dairy input cost pressure. Neutral rating. FedEx ( FDX) target raised at Citigroup to $108, Citigroup said. EBIT improvement target supports above consensus estimates. Buy rating. IAC/InterActiveCorp ( IACI) numbers raised at Oppenheimer. Shares of IACI now seen reaching $67, Oppenheimer said. Estimates also raised on numerous catalysts. Outperform rating. Eli Lilly ( LLY) target boosted at BofA/Merrill to $57, according to Bank of America/Merrill Lynch said. Sola should ultimately reach the market for Alzheimer's. Buy rating. LyondellBasell ( LYB) estimates raised at UBS through 2013, UBS said. Improved refining partially offsets weaker European OPO. Neutral rating and $49 price target. Progressive ( PGR) estimates, target raised at KBW. Shares of PGR now seen reaching $21, according to Keefe, Bruyette & Woods. Estimates also increased, given higher realized premium growth. Market Perform rating. Universal Health ( UHS) numbers raised at Credit Suisse. Shares of UHS now seen reaching $53, according to Credit Suisse. Estimates also increased, as the Ascend deal should add to earnings. Outperform rating. Yum! Brands ( YUM) numbers raised at UBS. Shares of YUM now seen reaching $84, UBS said. Estimates also increased on higher unit growth in China. Buy rating. YUM! Brands numbers raised at Jefferies. Shares of YUM now seen reaching $70, Jefferies said. Estimates also raised on solid EPS beat. Hold rating. >To submit a news tip, email: firstname.lastname@example.org.
READERS ALSO LIKE:
Twitter and become a fan on Facebook.